Media coverage and public awareness on bioethics perception of emerging biomedical therapiesReport as inadecuate




Media coverage and public awareness on bioethics perception of emerging biomedical therapies - Download this document for free, or read online. Document in PDF available to download.

Chinese Neurosurgical Journal

, 3:5

First Online: 19 January 2017Received: 14 July 2016Accepted: 08 December 2016

Abstract

Bioethics falls within the controversial ethical issues from the new advances and emerging technology in pre-clinical and clinical settings which inspired medical policy and practice. The purpose of this paper is to present an overview of ethical issues in stem cell-based therapies and to provide substantial argument for the need of a Bioethics Research Consortium that will be tasked with convening a disciplined board of experts that will apply their principles to biomedical research, and emerging technology to further stipulate the socioeconomic influence of such entities and their therapeutic impact to society. Not too long ago, the successful therapeutic studies in Parkinson’s disease and stroke were the highlights of bioethical issues. The precedent for study selection was based on public feedback, government reception, and scientific analyses developed by these spearhead studies. From all the negative publicity that researchers have been getting before, the whiplash from decades of fear and misunderstanding has hindered the progress of scientific study. There is a huge figurative tug of war between what is making profit and what is needed to improve the health of afflicted patients worldwide. Poor management of education and funding may have actually hindered potential life changing cures and treatments from coming to fruition. We propose the creation of a Bioethics Research Consortium that would determine how ethical matters are handled with careful consideration to public need. The goal is to restructure drug development policy, and improve upon the ways in which research methods and funds are handled today.

KeywordsEthics Embryonic stem cells Adult stem cells Transplantation AbbreviationsFDAU.S. Food and Drug Administration

INDInvestigational new drug

NIHNational Institute of Health

PDParkinson’s disease

USFUniversity of South Florida

Download fulltext PDF



Author: Sandra Acosta - Tam Tran - Jerel Mair - Obi Okonkwo - Brett Larose - Cesar V. Borlongan

Source: https://link.springer.com/







Related documents